Key facts
- This page summarizes Barry D. Quart's Form 4 filing for Kiniksa Pharmaceuticals International, plc (KNSA).
- 9 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 11 Jun 2025, 17:35.
Barry D. Quart - 09 Jun 2025 Form 4 Insider Report for Kiniksa Pharmaceuticals International, plc (KNSA)
- Reporting relationship
- Director
- Issuer ticker
- KNSA
- Reported as of
- 09 Jun 2025
- Net transaction value
- -$728,699
- SEC form
- 4
- Accepted by SEC
- 11 Jun 2025, 17:35:55 UTC
- Prior SEC filing
- 05 Jun 2025
- Next SEC filing
- 17 Dec 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Madelyn Zeylikman, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Barry D. Quart filed Form 4 for Kiniksa Pharmaceuticals International, plc (KNSA) on 11 Jun 2025.
Change
- Previous filing in this sequence was filed on 05 Jun 2025.
- Current net transaction value: -$728,699.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001384243
Primary reporting owner
Quart Barry D
- Relationship
- Director
- Address
- 23 OLD BOND STREET, THIRD FLOOR, LONDON, UNITED KINGDOM
- Signature
- /s/ Madelyn Zeylikman, Attorney-in-Fact
- Signature date
- 11 Jun 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
KNSA
transaction
Class A Ordinary Share
Options Exercise
- Transaction value
- $26,220
- Shares
- +6,900
- Change %
- +55%
- Price
- $3.80
- Shares after
- 19,446
- Date
- 09 Jun 2025
- Ownership
- Direct
KNSA
transaction
Class A Ordinary Share
Sale
- Transaction value
- $208,794
- Shares
- -6,900
- Change %
- -35%
- Price
- $30.26
- Shares after
- 12,546
- Date
- 09 Jun 2025
- Ownership
- Direct
KNSA
transaction
Class A Ordinary Share
Options Exercise
- Transaction value
- $31,206
- Shares
- +8,212
- Change %
- +65%
- Price
- $3.80
- Shares after
- 20,758
- Date
- 10 Jun 2025
- Ownership
- Direct
KNSA
transaction
Class A Ordinary Share
Sale
- Transaction value
- $249,316
- Shares
- -8,212
- Change %
- -40%
- Price
- $30.36
- Shares after
- 12,546
- Date
- 10 Jun 2025
- Ownership
- Direct
- Footnotes
- F1
KNSA
transaction
Class A Ordinary Share
Options Exercise
- Transaction value
- $46,877
- Shares
- +12,336
- Change %
- +98%
- Price
- $3.80
- Shares after
- 24,882
- Date
- 11 Jun 2025
- Ownership
- Direct
KNSA
transaction
Class A Ordinary Share
Sale
- Transaction value
- $374,891
- Shares
- -12,336
- Change %
- -50%
- Price
- $30.39
- Shares after
- 12,546
- Date
- 11 Jun 2025
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
KNSA
transaction
Derivative
Share Option
Options Exercise
- Transaction value
- $0
- Shares
- -6,900
- Change %
- -25%
- Price
- $0.000000
- Shares after
- 20,548
- Date
- 09 Jun 2025
- Ownership
- Direct
- Underlying class
- Class A Ordinary Share
- Underlying amount
- 6,900
- Exercise price
- $3.80
- Footnotes
- F3
KNSA
transaction
Derivative
Share Option
Options Exercise
- Transaction value
- $0
- Shares
- -8,212
- Change %
- -40%
- Price
- $0.000000
- Shares after
- 12,336
- Date
- 10 Jun 2025
- Ownership
- Direct
- Underlying class
- Class A Ordinary Shares
- Underlying amount
- 8,212
- Exercise price
- $3.80
- Footnotes
- F3
KNSA
transaction
Derivative
Share Option
Options Exercise
- Transaction value
- $0
- Shares
- -12,336
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 11 Jun 2025
- Ownership
- Direct
- Underlying class
- Class A Ordinary Shares
- Underlying amount
- 12,336
- Exercise price
- $3.80
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
This transaction was executed in multiple trades through a broker-dealer at prices ranging between $30.00 and $30.52. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
Footnote F2
This transaction was executed in multiple trades through a broker-dealer at prices ranging between $30.28 and $30.5801. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
Footnote F3
The option is fully vested and exercisable.